[Erythropoietin: receptor of stimulating agents of erythropoiesis].
Rieu
Philippe
P
Service de néphrologie et CNRS UMR 6198, Reims, France.
D000740:Anemia / Q000188:drug therapy; D000068256:Darbepoetin alfa; D004920:Erythropoiesis; D004921:Erythropoietin / Q000031:analogs & derivatives / Q000235:genetics / Q000378:metabolism* / Q000627:therapeutic use; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D050989:GATA2 Transcription Factor / Q000235:genetics; D006397:Hematinics / Q000378:metabolism; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D010766:Phosphorylation; D010770:Phosphotransferases / Q000378:metabolism; D011092:Polyethylene Glycols / Q000378:metabolism; D017467:Receptors, Erythropoietin / Q000378:metabolism*; D011994:Recombinant Proteins
D050989:GATA2 Transcription Factor; C497442:HIF1A protein, human; D006397:Hematinics; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D017467:Receptors, Erythropoietin; D011994:Recombinant Proteins; C508420:continuous erythropoietin receptor activator; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D011092:Polyethylene Glycols; D010770:Phosphotransferases; D048049:Extracellular Signal-Regulated MAP Kinases; D010100:Oxygen